HomeLALPATHLAB › Filing
🔔 Get instant alerts when LALPATHLAB files quarterly results on BSE Start free trial →
Dr. Lal Path Labs Ltd. (LALPATHLAB)

Attached

Filed: 25 Jul 2026, 17:00 IST Exchange: BSE Category: Corporate Action — Annual General Meeting Resolutions
32nd AGM held on July 25, 2026 via video conference - All 10 resolutions passed with requisite majority - Final dividend declared at Rs 4 per share for FY26 - Re-appointment of Mr. Rahul Sharma as Director - Revision and re-appointment of remuneration for Executive Chairman and Whole-Time Directors - Re-appointment of Mr. Rajit Mehta as Independent Director - Approval of remuneration and commission payments to Non-Executive Directors - Ratification of remuneration payable to Cost Auditors for FY27
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 LALPATHLAB — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add LALPATHLAB to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Dr. Lal Path Labs Ltd.

Important. The summary above is generated automatically from Dr. Lal Path Labs Ltd.'s own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.